540 Vemurafenib alters glucose utilization in BRAF-driven human melanoma cells (2014)
Attributed to:
Evaluation of non-invasive metabolic imaging biomarkers for novel RAF/MEK1/2-targeted anti-cancer agents
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0959-8049(14)70666-5
Publication URI: http://dx.doi.org/10.1016/s0959-8049(14)70666-5
Type: Journal Article/Review
Parent Publication: European Journal of Cancer